NCT06928194Completed
Reliability of Kinovea in Gait Assessment in Multiple Sclerosis: a Pilot Study.
Reliability of the Kinovea System in the Study of Spatiotemporal Gait Parameters in Multiple Sclerosis: a Pilot Study.
Source: ClinicalTrials.gov · Last updated 18 Apr 2025
Brief summary (registry, in English)
The objective of this observational study is to determine whether the Kinovea video analysis tool is valid and reliable for analyzing spatiotemporal gait parameters in multiple sclerosis, comparing the data obtained from this system with those of the gold standard, the GaitRite system. The main question to be answered is: Is the Kinovea system valid and reliable for analyzing spatiotemporal gait parameters in multiple sclerosis? Participants walked across the GAITRite platform four times without shoes and four times with shoes, while being recorded by two cameras simultaneously: one recorded gait from the sagittal plane and the other from the frontal plane.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 24 (actual)
- First submitted
- 7 Apr 2025
- Start date
- 10 Mar 2025
- Primary completion date
- 2 Apr 2025
- Lead sponsor
- University of Cadiz
- Diseases
- Multiple sclerosis
- NCT number
- NCT06928194
What you commit to
- Study type: Observational
- Participants enrolled: 24
- From 10 Mar 2025 to the primary completion date, 2 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have suffered a relapse within 30 days prior to the start of the study.
Other illness
- Patients with comorbidity or decompensated systemic disease within the last month.
Other
- Patients who use walking aids and/or orthoses.
- Patients who have any physical impediment (excessive fatigue) to performing the gait test, as documented in their medical records reviewed on the Diraya platform.
Who the study is looking for
- Patients scheduled for evaluation by the NeuroLab-Lázaro gait laboratory (Seville).
- Patients who have signed informed consent prior to the test.
- Patients between 18 and 55 years of age, diagnosed with MS according to the 2017 McDonald criteria.
- Patients with an EDSS score of less than 6.5 points.
- Patients who are willing to participate in the study and who do not object to being recorded while performing the gait test and to the use of images for educational and research purposes.
Age in the registry: 18 years to 55 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| NeuroLab-Lázaro Coordinator of this site? Confirm its status | Seville | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.